StockNews.com began coverage on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other analysts also recently issued research reports about the stock. Maxim Group reduced their price objective on shares of Coherus BioSciences from $15.00 […]
Yousif Capital Management LLC cut its stake in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 9.8% during the 1st quarter, HoldingsChannel reports. The firm owned 36,858 shares of the biotechnology company’s stock after selling 3,990 shares during the quarter. Yousif Capital Management LLC’s holdings in Coherus BioSciences were worth $252,000 as of its most […]